dr. sullivan discusses role of dabrafenib plus trametinib in melanoma
Published 4 years ago • 1.3K plays • Length 2:33Download video MP4
Download video MP3
Similar videos
-
1:15
dr. sullivan discusses the current treatment of melanoma
-
0:58
dr. sullivan on targeted therapy for braf-mutant melanoma
-
1:04
dr. wilson on long-term data with dabrafenib plus trametinib in melanoma
-
1:06
dr. ryan sullivan on treating braf-mutant patients with melanoma
-
2:16
dr. rodabe n. amaria on dabrafenib plus trametinib in melanoma
-
1:19
dr. robert on potential of dabrafenib/trametinib in melanoma brain metastases
-
2:07
dr. sullivan on considerations for treatment in metastatic melanoma
-
0:30
dr. postow on fda approval of adjuvant dabrafenib plus trametinib in braf-mutant melanoma
-
1:31
dr. daud on dabrafenib/trametinib vs immunotherapy in melanoma
-
0:48
dr. michael rotkowitz on the dabrafenib plus trametinib combination for melanoma
-
2:19
dr. robert on 5-year analysis of dabrafenib/trametinib in braf v600-mutant melanoma
-
1:27
dr. weber on side effects of dabrafenib/trametinib in melanoma
-
1:24
dr. algazi on benefit of continuous dabrafenib/trametinib dosing in braf melanoma
-
1:11
dr. weber on the fda approval of adjuvant dabrafenib/trametinib in braf-mutant melanoma
-
1:46
dr. weber on dabrafenib/trametinib approval for melanoma
-
0:53
dabrafenib plus trametinib demonstrates benefit in braf-mutant melanoma
-
1:52
dr. long on dabrafenib/trametinib in braf v600e-mutant melanoma
-
3:18
dabrafenib plus trametinib for the treatment of mnsclc
-
1:05
georgina long on treating melanoma with dabrafenib plus trametinib